Burcon NutraScience

Burcon NutraScience Equity

The The Equity of Burcon NutraScience (BU.TO) as of Oct 21, 2026 is -5.80 M CAD. In the previous year, The Equity was 6.94 M CAD — a change of -183.51% (lower).

Equity

-5.80 MCAD

YoY

-183.51%

Last updated:

In 2026, Burcon NutraScience's equity was -5.80 M CAD, a -183.51% increase from the 6.94 M CAD equity in the previous year.

The Burcon NutraScience Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2019
-1.98 M CAD
Jan 1, 2020
22.95 M CAD
Jan 1, 2021
36.27 M CAD
Jan 1, 2022
28.25 M CAD
Jan 1, 2023
4.14 M CAD
Jan 1, 2024
5.15 M CAD
Jan 1, 2025
6.94 M CAD
Jan 1, 2026
-5.80 M CAD
The Burcon NutraScience Equity history
YEAREquityYoY
-5.80 MCAD-183.51%
6.94 MCAD+34.74%
5.15 MCAD+24.56%
4.14 MCAD-85.35%
28.25 MCAD-22.13%
36.27 MCAD+58.08%
22.95 MCAD-1,258.82%
-1.98 MCAD-184.44%
2.35 MCAD-43.00%
4.11 MCAD+0.04%
4.11 MCAD-29.00%
5.79 MCAD+33.98%
4.32 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Burcon NutraScience Stock analysis

What does Burcon NutraScience do? Burcon NutraScience Corp develops plant-based protein products for the food and beverage industry, including Peazazz pea protein, Puratein and Supertein canola proteins, and CLARISOY soy protein. Peazazz serves as a dairy alternative, while Supertein and Puratein are used in baked goods, protein cereal bars, dressings, sauces, and meat substitutes. Puratein offers functional properties like emulsification, gel formation, thickening, and heat-stable foam formation. The company targets food and beverage manufacturers seeking sustainable protein solutions. The firm's products are sold to food and beverage companies that incorporate plant proteins into their formulations. CLARISOY functions as a dairy alternative with protein content matching dairy, appealing to manufacturers creating plant-based dairy products. Burcon's technology focuses on extraction and purification of renewable plant proteins, supporting the growing demand for functional ingredients in processed foods. Burcon's subsidiary develops a range of protein products, including Peazazz, Puratein, and Supertein, which are used across various food applications. The company's focus on functional properties such as emulsification and heat-stable foams differentiates its offerings in the plant protein market. Food manufacturers seeking sustainable, high-performance ingredients for dairy alternatives and meat substitutes are key customers. Burcon NutraScience is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Burcon NutraScience's Equity

Burcon NutraScience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Burcon NutraScience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Burcon NutraScience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Burcon NutraScience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Burcon NutraScience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Burcon NutraScience stock

The Equity of Burcon NutraScience is -5.80 M CAD in 2026.

The Equity of Burcon NutraScience changed from 6.94 M CAD to -5.80 M CAD, representing a -183.51% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Burcon NutraScience since 2006 – with annual values, charts, and detailed analysis.

The Equity's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Burcon NutraScience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Burcon NutraScience

All Key Metrics — Burcon NutraScience